Analysis of the Volume of the Liposuction-Derived Adipose Tissue in Clinical Application.
Yang R., Song Z., Li S., Wang J., Liang H.
Prospective Study, published in J Craniofac Surg (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- J Craniofac Surg (2025)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 39882880
- DOI
- 10.1097/SCS.0000000000011101
Abstract (original English)
Introduction The strategy of adipose component transplantation has been proposed and widely used in both reconstructive and aesthetic surgery. However, there is no uniform standard for the preparation of component fat, and the volume calculation of liposuction and injection in clinical applications is mostly based on experience. This study aims to analyze the volume of component fat obtained during clinical series. Methods Patients undergoing abdominal or thigh liposuction and autologous component fat grafting from September 2020 to October 2024 were included. The high-density fat was harvested from the inferior one-third layer of the standard Coleman fat. The SVF-gel was obtained by mechanical emulsification and centrifugation of the oil layer and upper two-third layer of adipose tissue. Correlation analysis was conducted between the volume of SVF-gel and patient characteristics. Results Sixty-five with an average age of 33.9 years were included. For breast augmentation, the volume of prepared high-density fat and SVF-gel were 331.7±70.8 and 60.3±13.1 mL, with the proportion of SVF in fat aspirated amounting to 6.4%±1.9%. For the treatment of temporal depression, the volume of prepared high-density fat and SVF-gel were 48.3±27.3 and 14.5±8.6 mL, respectively, with the proportion of SVF in fat aspirated amounting to 10.3%±2.0%. There was a significant difference between the pro
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.